Reader sentiment, not investment advice. One vote per visitor; click again to change it.
Twist Bioscience (TWST) is trading at $198.36, up 2.65% on the day. Its market value of $13.15B makes it the 732nd largest of the 800 companies we follow.
Shares are at a 52-week high, after a year that ran from $23.30 to $200.31.
9 analysts follow the stock and the average call is "buy". The mean target, $114.25, sits 42.4% under where the stock trades.
This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.
Composite of 2 factors below, ranked against the 800 U.S. stocks BeStock covers.
Trading closer to its 52-week high than most peers scores higher.
9 analysts, consensus Buy.
How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.
TWST is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.
Since 2020-07-06, the strategy has returned 1524.8% (321.7% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated weekly — not a guarantee of future results, and not a BeStock recommendation.
What Wall Street analysts and Morningstar's fair-value model expect for the stock
Wall Street’s average 12-month target is $114.25, 42.4% below today’s price, with a consensus rating of Buy.
Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.
Quote as of Oct 1, 2026 11:50 am ET. Prices can lag the live tape. This is background information, not a recommendation.
Ranks are among the 800 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.
$198.36 is the latest print for TWST, a move of +2.65% against yesterday's close of $193.24. Today's low and high so far: $191.66 and $200.31.
Equity value comes to $13.15B at the current price. By that measure it is number 732 of the 800 names in our coverage.
The year's floor is $23.30 and the ceiling $200.31. Shares are 1.0% away from that ceiling.
Our data shows no dividend paid by Twist Bioscience over the trailing twelve months.
Of 9 analysts, 78% say buy, 11% hold and 11% sell. Price targets average $114.25, with the most cautious at $45.00 and the most optimistic at $190.00.
BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.
No comments yet — be the first to weigh in on TWST.